Skip to main content
Wellcome Sanger Institute
Careers | Find us | Contact us
  • About
    • Our Vision
    • Our History
    • Careers
    • Study
    • Equality, Diversity and Inclusion
    • Leadership
    • Strategy and Funding
    • Influencing Policy
    • Research Policies
    • Branding and Logos
    • Admin Groups
    • Campus Connections
  • Science
    • Groups
    • Programmes
    • Collaborations
    • Tools
    • Data
    • Sanger Projects
    • COVID-19
    • Publications
    • Research Policies
    • Sanger Seminar Series
  • People
    • Leadership
    • Faculty
    • Associate Faculty
    • Honorary Faculty
    • International Fellows
    • Science Staff
    • Non-science Staff
    • Full A-Z
  • Innovation
    • Innovation at the Institute
    • For Industry
    • For Researchers
    • Case Studies
    • Our Spin-Outs
    • Sanger Technologies
  • News

We apply and explore genomic technologies at scale to advance understanding of biology and improve health

  • Mapping the evolution of E. coli’s main virulence factor offers a refined drug target

    Researchers have shown how targeting the bacterium’s protective capsule, which is linked to its virulence, could help prevent and treat bloodstream infections

    Find out more

  • New tool uncovers COVID-19 susceptibility mechanism

    Researchers have discovered a genetic mechanism that may explain some of the variation in the risk of COVID-19 infection

    Find out more

  • Single-cell atlas of the whole human lung

    First integrated Human Lung Cell Atlas reveals insights into lung diseases

    Find out more

  • Academy of Medical Sciences announces new Sanger Institute Fellows

    Wellcome Sanger Institute scientists, Dr Trevor Lawley, Professor Ben Lehner and Professor Julian Rayner have been elected as Fellows of the Academy of Medical Sciences in recognition of their contributions to science and health.

    Find out more

  • COSMIC welcomes Jon Teague as new director

    COSMIC (the Catalogue of Somatic Mutations in Cancer) - an Associate Research Programme at the Wellcome Sanger Institute - is delighted to welcome its new director, Jon Teague.

    Find out more

Meet our people: Life at the Sanger Institute

We have over 1,200 people at the Sanger Institute, from 70+ nationalities. We know that the success of our Institute depends on our people.

Explore what our employees, students, and alumni from across the Institute have to say about what they do, our culture and more.

Wellcome Sanger Institute

Our 2022/2023 Highlights document

Our Highlights document showcases the key discoveries and future research interests of our Scientific Programmes. These include vital insights into human, parasite and microbe evolution, cellular growth and activity, and the processes that underlie mutation and tumour formation. In addition, our Tree of Life Programme explores the diversity of complex life. ...more

 

Latest News and Blogs

David Gregory and Debbie Marshall, Wellcome Images, CC-BY-4.0

15 Jun 2023

Mapping the evolution of E. coli’s main virulence factor offers a refined drug target

Researchers have shown how targeting the bacterium’s protective capsule, which is linked to its virulence, could help prevent and treat ...

AdobeStock

14 Jun 2023

New tool uncovers COVID-19 susceptibility mechanism

Researchers have discovered a genetic mechanism that may explain some of the variation in the risk of COVID-19 infection

Nathan Richoz, University of Cambridge

8 Jun 2023

Single-cell atlas of the whole human lung

First integrated Human Lung Cell Atlas reveals insights into lung diseases

Sanger Logo

Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244

  • About
  • Legal
  • Data sharing
  • Careers
  • Privacy
  • Equality, Diversity, Inclusion
  • Study
  • Modern Slavery Statement
ROSPA Gold
Athena Swan

Expand footer

Wellcome Sanger Institute, Genome Research Limited (reg no. 2742969) is a charity registered in England with number 1021457

2023 Wellcome Sanger Institute | All rights reserved